TERNTERNS PHARMACEUTICALS INC
CUSIP 880881107 · common stock
No tracked investor reported shares of TERNS PHARMACEUTICALS INC (TERN) for Q2 2026. 4 investors sold out this quarter, including Adar1 Capital Management.
Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding TERN · Q2 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Adar1 Capital Management | 2.84% | 914,699 | $48.2M | EXIT |
| George Soros | 0.19% | 321,905 | $17M | EXIT |
| Ron Baron | 0.01% | 35,000 | $1.8M | EXIT |
| Joel Greenblatt | 0.00% | 16,497 | $869.7K | EXIT |